Fibrotic Scar in Neurodegenerative Diseases
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The process of uncontrolled internal scarring, called fibrosis, is now emerging as a pathological feature shared by both peripheral and central nervous system diseases. In the CNS, damaged neurons are not replaced by tissue regeneration, and scar-forming cells such as endothelial cells, inflammatory immune cells, stromal fibroblasts, and astrocytes can persist chronically in brain and spinal cord lesions. Although this process was extensively described in acute CNS damages, novel evidence indicates the involvement of a fibrotic reaction in chronic CNS injuries as those occurring during neurodegenerative diseases, where inflammation and fibrosis fuel degeneration. In this mini review, we discuss recent advances around the role of fibrotic scar formation and function in different neurodegenerative conditions, particularly focusing on the rising role of scarring in the pathogenesis of amyotrophic lateral sclerosis, multiple sclerosis, and Alzheimer's disease and highlighting the therapeutic relevance of targeting fibrotic scarring to slow and reverse neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Astrocyte scar formation aids central nervous system axon regeneration
Anderson, M. A., Burda, J. E., Ren, Y., Ao, Y., O’Shea, T. M., Kawaguchi, R., Coppola, G., Khakh, B. S., Deming, T. J., & Sofroniew, M. V. (2016) · Nature · doi:10.1038/nature17623 · Cited by 1,851 · cited 1×
“Conversely, it has also been reported that astrocytic scar formation may not only have a detrimental role, but it also helps CNS axonal regeneration by forming permissive bridges in vivo, known as glial bridges, along which injured CNS axons can regrow and cross the scar when stimulated with appropriate growth factors…”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Transfer of mitochondria from astrocytes to neurons after stroke
Hayakawa, K., Esposito, E., Wang, X., Terasaki, Y., Liu, Y., Xing, C., Ji, X., & Lo, E. H. (2016) · Nature · doi:10.1038/nature18928 · Cited by 1,423 · cited 1×
“For instance, reactive astrocytes appearing after a stroke acquire a repairing phenotype, characterized by the upregulation of neurotrophic factors expression and by the translocation of mitochondrial particles to damaged neurons (13).”
BackgroundA Pericyte Origin of Spinal Cord Scar Tissue
Göritz, C., Dias, D. O., Tomilin, N., Barbacid, M., Shupliakov, O., & Frisén, J. (2011) · Science · doi:10.1126/science.1203165 · Cited by 858
Blood–spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis
Winkler, E. A., Sengillo, J. D., Sullivan, J. S., Henkel, J. S., Appel, S. H., & Zlokovic, B. V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-012-1039-8 · Cited by 354 · cited 1×
“Furthermore, the loss of pericytes in the blood-brain and blood-spinal cord barrier, a well-established pathogenic mechanism in ALS, correlated with the worsening of the disease, leads to accumulation of blood cells and proteins (such as immunoglobulin G, fibrin and thrombin) in the CNS (45).”
BackgroundAstrocytes as a Source for Extracellular Matrix Molecules and Cytokines
Wiese, S., Karus, M., & Faissner, A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00120 · Cited by 262
Targeting the neural extracellular matrix in neurological disorders
Soleman, S., Filippov, M. A., Dityatev, A., & Fawcett, J. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.08.050 · Cited by 244 · cited 1×
“ECM components form dense lattice-like structures surrounding neurons, termed perineuronal nets (PNNs), that in the long-term hamper neural plasticity and axon regeneration and growth (9).”
BackgroundEndo, F., Komine, O., Fujimori-Tonou, N., Katsuno, M., Jin, S., Watanabe, S., Sobue, G., Dezawa, M., Wyss-Coray, T., & Yamanaka, K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.053 · Cited by 207 · cited 1×
“In this respect, mainly astrocytes and microglia produce and release TGFβ that may act on myofibroblasts precursors to induce a profibrotic phenotype (27, 28).”
BackgroundThe perivascular origin of pathological fibroblasts
Di Carlo, S. E., & Peduto, L. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93558 · Cited by 164 · cited 1×
“Together with S100A4, vimentin and fibronectin, α-smooth muscle actin (α-SMA) is commonly used to identify activated mesenchymal cells surrounding CNS blood vessels which are a major source of injury-induced myofibroblasts after damage (41, 42).”
BackgroundYahn, S. L., Li, J., Goo, I., Gao, H., Brambilla, R., & Lee, J. K. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104674 · Cited by 45
Pericytes: Problems and Promises for CNS Repair
Laredo, F., Plebanski, J., & Tedeschi, A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00546 · Cited by 44 · cited 2×
“An increasing attention is now given to the role of pericyte cells as an attractive target involved in the pathogenesis, progression and potential treatment of AD (18).”
BackgroundResult
Cited by
Astrocytes in human central nervous system diseases: a frontier for new therapies
Verkhratsky, A., Butt, A., Li, B., Illes, P., Zorec, R., Semyanov, A., Tang, Y., & Sofroniew, M. V. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01628-9 · Cited by 428
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Zang, X., Chen, S., Zhu, J., Ma, J., & Zhai, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.872134 · Cited by 139
“Therefore, it has been suggested that converting the fibrosis-supporting matrix deposition state of astrocytes and myofibroblasts to a fibrosissupporting regressive or reversible matrix degradation state and reducing scar formation may help to improve the pathological processes of amyotrophic lateral sclerosis (ALS) a…”
BackgroundThe role of neural stem cells in regulating glial scar formation and repair
Nicaise, A. M., D’Angelo, A., Ionescu, R.-B., Krzak, G., Willis, C. M., & Pluchino, S. (2022) · Cell and Tissue Research · doi:10.1007/s00441-021-03554-0 · Cited by 65
Astrocytes and Microglia in Stress-Induced Neuroinflammation: The African Perspective
Olude, M. A., Mouihate, A., Mustapha, O. A., Farina, C., Quintana, F. J., & Olopade, J. O. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.795089 · Cited by 37
“This reaction alters physiological tissue topology and may lead to scar formation as observed in traumatic, neuroinflammatory and neurodegenerative CNS disorders (3, 4).”
BackgroundDissecting the evolving cellular landscape of a remyelinating microenvironment
Melchor, G. S., Baydyuk, M., Manavi, Z., Hu, J., & Huang, J. K. (2024) · doi:10.1101/2024.12.25.630253 · Cited by 3
Metadata
- Authors
- D'Ambrosi, N., & Apolloni, S.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-08-14
- Volume
- 11
- Pages
- 1394-1394
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3085439834
- Cited by
- 75
- References
- 12
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.